Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 32.70% vs -37.99% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 18.18% vs 0.00% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -1.20% vs -1.32% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 16.36% vs 5.95% in Mar 2024
Compare Balance Sheet Results of Shukra Pharma.
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
43.79
13.28
30.51
229.74%
Share Warrants & Outstandings
Total Reserve
19.05
204.71
-185.66
-90.69%
Shareholder's Funds
62.84
239.95
-177.11
-73.81%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
3.11
0.00
3.11
0.00%
Secured Loans
1.64
0.00
1.64
0.00%
Unsecured Loans
1.48
0.00
1.48
0.00%
Deferred Tax Assets / Liabilities
3.41
3.07
0.34
11.07%
Other Long Term Liabilities
0.13
8.30
-8.17
-98.43%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
1.04
-1.04
-100.00%
Total Non-Current Liabilities
6.65
12.41
-5.76
-46.41%
Current Liabilities
Trade Payables
9.22
9.73
-0.51
-5.24%
Other Current Liabilities
4.27
15.16
-10.89
-71.83%
Short Term Borrowings
1.06
0.00
1.06
0.00%
Short Term Provisions
2.74
1.01
1.73
171.29%
Total Current Liabilities
17.28
25.90
-8.62
-33.28%
Total Liabilities
86.77
278.26
-191.49
-68.82%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
43.42
93.47
-50.05
-53.55%
Less: Accumulated Depreciation
24.03
7.25
16.78
231.45%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
19.40
86.23
-66.83
-77.50%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
1.95
0.00
1.95
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
0.00
1.33
-1.33
-100.00%
Other Non Current Assets
0.00
21.29
-21.29
-100.00%
Total Non-Current Assets
21.34
117.07
-95.73
-81.77%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
9.95
15.20
-5.25
-34.54%
Sundry Debtors
8.77
13.18
-4.41
-33.46%
Cash and Bank
12.12
128.73
-116.61
-90.58%
Other Current Assets
20.17
1.66
18.51
1,115.06%
Short Term Loans and Advances
14.42
2.42
12.00
495.87%
Total Current Assets
65.43
161.19
-95.76
-59.41%
Net Current Assets (Including Current Investments)
48.14
135.29
-87.15
-64.42%
Total Current Assets Excluding Current Investments
65.43
161.19
-95.76
-59.41%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
86.77
278.26
-191.49
-68.82%
Contingent Liabilities
1.40
16.17
-14.77
-91.34%
Total Debt
4.18
0.00
4.18
0.00%
Book Value per share (adjusted)
1.44
36.08
-34.64
-96.01%
Annual - Borrowings
Borrowings 4.18 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 32.70% vs -37.99% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.13 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 18.18% vs 0.00% in Mar 2024
Annual - Fixed Assets
Fixed Assets 21.34 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -1.20% vs -1.32% in Mar 2024
Annual - Investments
Investments 0.00 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 65.43 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 16.36% vs 5.95% in Mar 2024
